MediBloc X Harvard Medical School Massachusetts General Hospital research

We are thrilled to announce that MediBloc is collaborating with Massachusetts General Hospital(MGH), the original and largest teaching hospital of Harvard Medical School!

MGH is the largest and most historic hospital among Harvard Medical School hospitals and is the leading medical institution in the United States, along with Mayo Clinic and Johns Hopkins Hospital. MGH is also a hands-on training hospital for graduates of Harvard Medical School. We are thrilled to conduct medical research with such a prestigious institution and have our platform recognized as a world-class technology. It conducts the largest hospital-based research program in the United States, with an annual research budget of over $900 million.

The 3-year project will focus on 1) EHR enhancement for standardized data exchange and 2) network stabilization to enable seamless health data sharing. In addition, we plan to implement AI services developed by LMIC Lab* and second opinion services through utilizing MediBloc platform.

LMIC (Laboratory of Medical Imaging and Computation) is a lab that studies computerized methods for analyzing medical records and medical images. The lab is developing deep learning-based medical AI solutions and has received much attention from the medical community as one of the leaders in medical image AI, that has developed various solutions for bone age evaluation, muscle mass quantification, cerebral hemorrhage diagnosis, and others.

MGH will work with MediBloc to enhance their EHR systems focusing on building a standardized data exchange. EHR systems are traditionally fragmented across institutions and MediBloc will enable better data security and interoperability of personal health information between MGH and other hospitals and clinics.

As a result, MGH will become one of the first institutions to leverage blockchain technology for secure and accessible data storage across multiple EHR systems, leading to more comprehensive patient profiles. Patients will be granted much easier access to their PHI and will retain sovereignty over their medical data. Easier access to targeted healthcare data in a standardized interface benefits researchers, healthcare providers, and patients alike. MGH’s role in the collaboration will provide an important benchmark for improving the security and accessibility of medical data in the industry.

Dr. Eunsol Lee, co-CEO and co-founder of MediBloc, said, “Collaborating with MGH, the most prestigious institution in the states, is an excellent opportunity for us to prove the feasibility of our platform, as well as expand the scope of the platform using LMIC lab’s AI platform. Starting with MGH, we will expand our presence in the global market.”

Dr. Myeongchan Kim of LMIC, project leader, said, “We are delighted to work with the leader of blockchain-based medical information platforms.” The two teams will be co-working on creating best practices and standards for blockchain-based healthcare information systems.

MediBloc has signed strategic partnership agreements with various institutions including Hanyang University Medical Center, Kyunghee University Dental Hospital, and Bestian foundation, to prove its feasibility as a medical data platform. In addition, the team has been selected as the sole provider of blockchain technology for two government-funded projects, which are led by Bundang Seoul National University Hospital and Seoul St. Mary’s hospital.

The team will continue to expand the business globally and accelerate the commercialization of MediBloc platform. We appreciate everyone’s continued support!